Ahmet Oruç

8PUBLICATIONS
99CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 25, 2026
Clinical and Social Determinants of Treatment Adherence in Cancer Patients: The Contributory Role of Hearing Loss.

|Feb 11, 2026
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group.

Salih Tunbekici, Hamit Bal, Oguzcan Kınıkoglu

|Jan 24, 2026
Evaluation of inflammatory parameters and ferritin as prognostic factors in non-small cell lung cancer patients receiving nivolumab immunotherapy.

İsmail Beypınar, Onur Yazdan Balçık, Semiha Urvay

|Dec 24, 2025
Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety.

Büşra Bülbül, Bekir Ucun, Can Cangür

|Dec 19, 2025
The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study.

Bilgeşah Kılıçtaş, Murat Araz, Ahmet Oruç

|Sep 26, 2025
Impact of Body Composition on Progression-Free Survival in Patients with Metastatic Breast Cancer Treated with Ribociclib.

Ahmet Oruç, Mustafa Erol, Özlem Şahin

Pageof 2

Frequent Collaborators

6 joint publications

Murat Araz

4 joint publications

Melek Karakurt Eryılmaz

3 joint publications

Mehmet Artaç

2 joint publications

İsmail Beypınar